Overview
Reza Mojtabavi is an Internal Medicine provider in Las Vegas, Nevada. Dr. Mojtabavi and is rated as an Experienced provider by MediFind in the treatment of Long QT Syndrome 2. His top areas of expertise are Pneumonia, COVID-19, Ventricular Tachycardia, Prostatic Artery Embolization, and Endoscopy. Dr. Mojtabavi is currently accepting new patients.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Locations
3150 N Tenaya Way, Suite 240, Las Vegas, NV 89128
9300 W Sunset Rd, Las Vegas, NV 89148
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Reza Mojtabavi
Sarah Heiner is an Internal Medicine provider in Henderson, Nevada. Dr. Heiner and is rated as an Advanced provider by MediFind in the treatment of Long QT Syndrome 2. Her top areas of expertise are Vitamin D Deficiency, Scoliosis, Postmenopausal Osteoporosis, and Osteoporosis.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Pneumonia
- Advanced
- Acute Kidney Failure
- Atypical Pneumonia
- Cellulitis
- Childhood Iron Deficiency Anemia
- Chromophobe Renal Cell Carcinoma
- Coronary Heart Disease
- Experienced
- Absence Seizure
- Acute Coronary Syndrome
- Acute Cystitis
- Acute Pancreatitis
- Acute Tubular Necrosis
- ALK-Positive Non-Small Cell Lung Cancer